serratamolide has been researched along with B-Cell Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Escobar-Díaz, E; García-Marco, JA; Garcia-Pardo, A; Giralt, E; Hernández del Cerro, M; López-Martín, EM; Montaner, B; Pérez-Tomás, R; Puig-Kroger, A; Soto-Cerrato, V | 1 |
1 other study(ies) available for serratamolide and B-Cell Leukemia
Article | Year |
---|---|
AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Caspases; Cell Survival; Cytochromes c; Depsipeptides; Humans; In Vitro Techniques; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Luciferases; Membrane Potentials; Mice; Mice, Transgenic; Mitochondria; NF-kappa B; Peptides, Cyclic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Serratia marcescens; Transfection | 2005 |